Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines.
作者信息
Maestroni Georges
机构信息
Center of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
出版信息
J Neuroimmune Pharmacol. 2020 Dec;15(4):572-573. doi: 10.1007/s11481-020-09956-1. Epub 2020 Sep 10.
Abstract
摘要
相似文献
1
Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines.
J Neuroimmune Pharmacol. 2020 Dec;15(4):572-573. doi: 10.1007/s11481-020-09956-1. Epub 2020 Sep 10.
2
The role of vitamin D as a potential adjuvant for COVID-19 vaccines.
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5323-5327. doi: 10.26355/eurrev_202109_26637.
3
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant.
Chem Commun (Camb). 2021 Jan 14;57(4):504-507. doi: 10.1039/d0cc06959k. Epub 2020 Dec 17.
4
IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.
Front Immunol. 2021 Sep 17;12:737406. doi: 10.3389/fimmu.2021.737406. eCollection 2021.
5
Could mixing COVID vaccines boost immune response?
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
6
Exploring the possible use of saponin adjuvants in COVID-19 vaccine.
Hum Vaccin Immunother. 2020 Dec 1;16(12):2944-2953. doi: 10.1080/21645515.2020.1833579. Epub 2020 Dec 9.
7
Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.
Emerg Microbes Infect. 2021 Dec;10(1):439-441. doi: 10.1080/22221751.2021.1896956.
8
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals.
J Neuroimmune Pharmacol. 2021 Sep;16(3):517-518. doi: 10.1007/s11481-021-09998-z. Epub 2021 May 18.
9
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
10
A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.
Sci Adv. 2021 Feb 5;7(6). doi: 10.1126/sciadv.abe5819. Print 2021 Feb.
引用本文的文献
1
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS).
Hum Vaccin Immunother. 2024 Dec 31;20(1):2419742. doi: 10.1080/21645515.2024.2419742. Epub 2024 Nov 13.
2
knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response.
iScience. 2023 Aug 29;26(9):107593. doi: 10.1016/j.isci.2023.107593. eCollection 2023 Sep 15.
3
Can melatonin reduce the severity of post-COVID-19 syndrome?
EXCLI J. 2023 Feb 2;22:173-187. doi: 10.17179/excli2023-5864. eCollection 2023.
4
Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review.
Curr Issues Mol Biol. 2021 Dec 22;44(1):31-45. doi: 10.3390/cimb44010003.
5
Melatonin as the Cornerstone of Neuroimmunoendocrinology.
Int J Mol Sci. 2022 Feb 6;23(3):1835. doi: 10.3390/ijms23031835.
6
Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.
Int J Mol Sci. 2021 Aug 11;22(16):8623. doi: 10.3390/ijms22168623.
7
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.
Antioxidants (Basel). 2021 Jul 20;10(7):1152. doi: 10.3390/antiox10071152.
8
Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?
Diseases. 2020 Nov 26;8(4):44. doi: 10.3390/diseases8040044.
本文引用的文献
1
The inhibition of IL-2/IL-2R gives rise to CD8 T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.
Cell Death Dis. 2020 Jun 8;11(6):429. doi: 10.1038/s41419-020-2636-4.
2
Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
Pathog Dis. 2020 Apr 1;78(3). doi: 10.1093/femspd/ftaa025.
3
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
4
Can melatonin reduce the severity of COVID-19 pandemic?
Int Rev Immunol. 2020;39(4):153-162. doi: 10.1080/08830185.2020.1756284. Epub 2020 Apr 29.
5
Boosting immune system against cancer by melatonin: A mechanistic viewpoint.
Life Sci. 2019 Dec 1;238:116960. doi: 10.1016/j.lfs.2019.116960. Epub 2019 Oct 17.
6
Melatonin enhances responsiveness to Dichelobacter nodosus vaccine in sheep and increases peripheral blood CD4 T lymphocytes and IgG-expressing B lymphocytes.
Vet Immunol Immunopathol. 2018 Dec;206:1-8. doi: 10.1016/j.vetimm.2018.11.006. Epub 2018 Nov 8.
7
The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors.
Front Immunol. 2018 Aug 22;9:1914. doi: 10.3389/fimmu.2018.01914. eCollection 2018.
8
Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Arch Virol. 2018 Mar;163(3):587-597. doi: 10.1007/s00705-017-3647-z. Epub 2017 Nov 17.
9
Update on melatonin receptors: IUPHAR Review 20.
Br J Pharmacol. 2016 Sep;173(18):2702-25. doi: 10.1111/bph.13536. Epub 2016 Aug 8.
10
Melatonin: Physiological effects in humans.
Neurochirurgie. 2015 Apr-Jun;61(2-3):77-84. doi: 10.1016/j.neuchi.2015.03.002. Epub 2015 Apr 20.
Zotero 插件